Galectin Therapeutics Inc. (GALT)

NCM – Real vaqt narxi. Valyuta: USD

2.25

+0.04 (1.81%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Kompaniya haqida

Galectin Therapeutics Inc., klinik bosqichdagi biopilashuv kompaniyasi, fibroz kasalliklari va saraton uchun yangi davolash usullarini yaratish uchun dori ishlab chiqish bilan shug'ullanadi. Kompaniyaning asosiy mahsulot nomzodi belapektin (GR-MD-02) hisoblanadi, bu galectin-3 inhibitori bo'lib, u ilg'or fibrozli MASH bemorlarida 2-bosqich klinik tadqiqotda va kompensatsiyalangan sirroz va portal gipertenziyali MASH bemorlarida ikkinchi 2b-bosqich klinik sinovida. Kompaniya SBH Sciences, Inc. tomonidan birgalikda egalik qilinadigan qo'shma korxonaga ega bo'lib, u og'iz orqali yuboriladigan galectin-3 ning kichik organik molekulyar inhibitorlarini tadqiq qilish va ishlab chiqish uchun mo'ljallangan. Kompaniya ilgari Pro-Pharmaceuticals, Inc. nomi bilan tanilgan va 2011 yil may oyida Galectin Therapeutics Inc. nomini o'zgartirgan. Galectin Therapeutics Inc. 2000 yilda tashkil etilgan va Norcross, Jorjiya shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. Khurram Jamil M.D.	Chief Medical Officer
Mr. Jack W. Callicutt CPA	CFO, Treasurer & Corporate Secretary
Mr. Jim Wilkins Ph.D.	Head of CMC & Pharmaceutical Development
Mr. Joel Lewis CPA	President & CEO
Mr. Robert Tritt J.D.	General Counsel
Ms. Beth Knowles	Executive Assistant & Officer Manager